MORRISVILLE, NC – Centice Corporation, a pioneer in chemical verification and identification using Raman spectroscopy and computational sensor technology, announced today the sale of the new PINPOINT Rx™ drug identification system designed to assist hospital pharmacists with identifying prescription pills, pill fragments and material suspected to be prescription drugs. Integrating hardware sensing technology for chemical analysis and the Medi-Span® database software, the system matches the chemical composition with descriptive information to quickly find a match automatically, without human intervention. The product provides an alternative to visual identification, internet searches and commercial databases.

“We are asked to identify pills several times a week that are brought into the hospital by emergency personnel or by the patient’s family members. We sought a simpler, more accurate method to respond to physicians’ requests for pill identification” said Pharmacy Director Robert Moura. “The system is very simple to use and will provide additional record keeping capability for the hospital.”

“The PINPOINT Rx™ product demonstrates Centice’s commitment to improving healthcare in the U.S. with advances in technology” said Centice Corporation CEO Scott Albert. “Our core technology advances patient safety by solving needs at more affordable costs.”

About Centice

Centice Corporation creates and delivers advanced technology solutions to select markets in pharmacy operations, healthcare, manufacturing and homeland security. By leveraging an expertise in applied Raman spectroscopy, computational sensors, and machine vision technology, Centice provides products and integration expertise that saves lives and protects people’s lifestyles. Centice’s scientists and engineering teams work with a network of partners to answer emerging business and public service needs. Headquartered in Morrisville, N.C. and founded in 2004, the company maintains sales offices across the country and markets products direct and through distributors.